Refractory Prostate Carcinoma
1 clinical trials · Condition
◉ Watch Refractory Prostate Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer (NCT05828082) | National Cancer Institute (NCI) | 2023-10-16 |
Track Refractory Prostate Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.